Industry Healthcare Founded 1991 Type Privately held company | Website www.diaverum.com Number of employees 9,000 | |
 | ||
Key people Dag Andersson, President and CEO Services Dialysis and renal care Subsidiaries Stair Société Traitement Autonome Insuffisance Rénale Profiles | ||
Diaverum promotional video
Diaverum is a provider of renal healthcare with about 300 clinics in Latin America, Europe, Asia, Australia and the Middle East.
Contents
Diaverum saudi arabia
History
Diaverum was originally part of the Swedish company Gambro, founded in Lund, Sweden in 1964. Gambro opened its first dialysis clinic in Lund in 1991. The clinic activities expanded under the name Gambro Healthcare and by 2005 the company managed 150 dialysis clinics worldwide. Gambro Healthcare was divested from Gambro in 2007 and taken over by Bridgepoint Capital, a major private healthcare investor in Europe, and the company management. The name Diaverum was adopted in 2008. Today, Diaverum is led by Dag Andersson, President and CEO and his executive team.
It established a contract with IWantGreatCare in 2012 to allow its customers to provide feedback. Responses are collected and analysed in multiple languages for an initial roll out covering the UK and Spain.
Since the Health and Social Care Act 2012 came into force in April 2013 the company has been awarded three contracts worth at least £150m.
Service offer
Diaverum describes itself as integrated renal care provider offering renal care from preventive and early stage to renal replacement therapies:
Medical research
Diaverum also conducts clinical research, under the direction of the company’s scientific director Giovanni FM Strippoli. The research focuses on preventing or minimising the risks for dialysis, making dialysis more effective, finding solutions to minimise risks of dialysis side effects, and finding proof of the efficacy of dialysis related drugs. The research has been published in international medical journals such as The Lancet, the New England Journal of Medicine and the Clinical Journal of the American Society of Nephrology.